Breast Cancer
New Therapies
Liquid gold: blood-based biopsies make headway
Conference Coverage
Safe to avoid sentinel node biopsy in some breast cancer patients
SEATTLE – Sentinel node biopsy can be safely avoided in certain populations of breast cancer patients.
Conference Coverage
Survivorship care models work, some better than others
ORLANDO – Survivorship care models can reduce health care use and costs without compromising outcomes, but quality of care differs across models...
Feature
Unavoidable, random DNA replication errors are the most common cancer drivers
Up to two-thirds of the mutations that drive human cancers may be due to DNA replication errors in normally dividing stem cells, not by inherited...
Conference Coverage
Breast cancer info on centers’ sites leaves room for improvement
ORLANDO – The websites of leading cancer centers often fail to provide critical information about breast cancer treatment.
News
FDA approves ribociclib for HR+, HER2– advanced breast cancer
The Food and Drug Administration has approved ribociclib, a cyclin-dependent kinase (CDK) 4/6 inhibitor, in combination with an aromatase...
Conference Coverage
VIDEO: Sexuality, fertility are focus of cancer education website
MIAMI BEACH – Cancer patients may be reticent to discuss issues of sexuality and fertility related to their disease. At the same time, their...
Conference Coverage
VIDEO: Residual cancer burden may be better outcome measure than pCR
MIAMI BEACH – The Food and Drug Administration has accepted pathological complete response rate (pCR) as a surrogate endpoint for disease-free and...
Conference Coverage
VIDEO: Genomics, other advances further highlight how breast cancer differs in men
MIAMI BEACH – Men’s version of breast cancer differs so significantly from women’s that it is unreasonable to extrapolate findings from one to the...
Conference Coverage
VIDEO: It’s too early to give up on immunotherapy for breast cancer
MIAMI BEACH – Breast cancer is less immunogenic that melanoma, bladder cancer, lung cancer, and other malignancies that have responded well to...
Conference Coverage
VIDEO: Multiple PARP inhibitors show promise in breast cancer treatment
MIAMI BEACH – Driven by efficacy demonstrated in ovarian cancer, a number of PARP inhibitors are in development and hold promise for treatment of...